Early research (Phase 1)UnknownNCT06367673What this trial is testingNatural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid LeukemiaWho this might be right forAML, Adult Zhejiang University 24
Early research (Phase 1)Ended earlyNCT03135028What this trial is testingEntospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese AdultsWho this might be right forHematologic MalignancyAcute Myeloid Leukemia Gilead Sciences 9
Early research (Phase 1)Study completedNCT03263637What this trial is testingStudy to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesWho this might be right forRelapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more AstraZeneca 44
Not applicableEnded earlyNCT05247957What this trial is testingNKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forSafety and Efficacy Hangzhou Cheetah Cell Therapeutics Co., Ltd 9
Testing effectiveness (Phase 2)Study completedNCT00064311What this trial is testingRavuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04521231What this trial is testingSubcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLWho this might be right forB Cell Precursor Acute Lymphoblastic Leukemia Amgen 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628What this trial is testingInotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more Children's Oncology Group 80
Testing effectiveness (Phase 2)Looking for participantsNCT06585345What this trial is testingClinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute LeukemiaWho this might be right forAcute-Leukemia The General Hospital of Western Theater Command 200
Early research (Phase 1)Active Not RecruitingNCT00840853What this trial is testingMulti-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRATWho this might be right forAcute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma Baylor College of Medicine 68
Not applicableStudy completedNCT02003612What this trial is testingHistorical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Amgen 2,373
Large-scale testing (Phase 3)Looking for participantsNCT07570173What this trial is testingA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Who this might be right forB-cell Acute Lymphoblastic Leukemia Merck Sharp & Dohme LLC 340
Testing effectiveness (Phase 2)Study completedNCT01279473What this trial is testingStudy to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)Who this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 42
Not applicableNot Yet RecruitingNCT07245251What this trial is testingTo Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004Who this might be right forAcute Lymphobkastic Leukemia Starna Therapeutics 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03625037What this trial is testingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaWho this might be right forDLBCLHigh-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+6 more Genmab 666
Early research (Phase 1)Active Not RecruitingNCT06618001What this trial is testingJNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Neoplasms Janssen Research & Development, LLC 64
Very early researchUnknownNCT05480501What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Ended earlyNCT02412475What this trial is testingEpigenetic Reprogramming in Relapse AMLWho this might be right forLeukemia, Acute Myeloid Michael Burke 3
Testing effectiveness (Phase 2)Study completedNCT00512083What this trial is testingPhase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid LeukemiaWho this might be right forLeukemia, Myeloid Antisoma Research 70
Large-scale testing (Phase 3)Study completedNCT00090051What this trial is testingFCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed PatientsWho this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 552